You are here : Home>Formulary Search>
Co-proxamol (Dextropropoxyphene hydrochloride/para - Pain
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
At the Surrey and North-West Sussex Area Prescribing Committee (APC) held in June 2020, it was decided that all BLACK status drugs would have their review dates extended for 5 years without the need for a review.
If a clinician or provider wishes to change the traffic light status of any BLACK drug then they will need to submit a paper for change as per usual APC process.
The Prescribing Clinical Network does not recommend the use of co-proxamol.
Co-proxamol will be considered BLACK on the traffic light system. Prescribers should: - NOT initiate co-proxamol for any new patient AND - Switch patients taking co-proxamol to an alternative pain medication, in line with NHS England guidance.
